Ethacizine
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Overview
Ethacizine (ethacyzine) is a class Ic antiarrhythmic agent, related to moracizine. It is used in Russia and some other CIS countries for the treatment of severe and/or refractory ventricular and supraventricular arrhythmias, especially those accompanied by organic heart disease. It is also indicated as a treatment of refractory tachycardia associated with Wolff–Parkinson–White syndrome.[1]
It is manufactured under the brand name Ethacizin (Этацизин) by Olainfarm.[2]
References
References
- ↑ 1.0 1.1 “Этацизин (Ethacyzin) Prescribing Information. VIDAL Drug Compendium” (in Russian). Retrieved 5 February 2014.
- ↑ “Этацизин—4DOKTOR.RU Drug Information Handbook” (in Russian). Retrieved 5 February 2014.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH